YFI Drops 43.91% Over the Past Year as Price Continues to Fall
- YFI fell 1.64% in 24 hours to $4,510, extending a 43.91% annual decline amid sustained bearish momentum. - Technical indicators show a "death cross" pattern and oversold RSI, signaling prolonged downward pressure without reversal catalysts. - Analysts attribute the decline to macroeconomic uncertainty and shifting risk appetite, predicting continued volatility and structural bear trends.
As of November 17, 2025, YFI saw its price decrease by 1.64% over the previous 24 hours, settling at $4,510. This decline extends an ongoing downward trajectory, with the asset dropping 6.08% in the past week, 4.77% over the last month, and a notable 43.91% over the previous year. These price changes reflect a prevailing bearish mood in the market, with little indication of a near-term recovery or stabilization.
Technical analysis points to the persistence of this negative trend. Both the 50-day and 200-day moving averages are trending downward, and the 50-day average has recently slipped below the 200-day, forming a bearish "death cross." Moreover, the Relative Strength Index (RSI) has stayed in oversold territory for a prolonged period, signaling weak buying interest and a potential depletion of short-term bullish energy. This technical picture supports expectations for continued price weakness unless a significant positive catalyst emerges.
Market sentiment seems to be shaped more by broader macroeconomic instability and changing investor risk preferences than by any YFI-specific developments. Experts anticipate ongoing volatility and the possibility of further declines in this asset class, especially in conditions of limited liquidity and persistent inflationary signals from economic data. The steady drop over the past year indicates that YFI is likely in a structural bear market, rather than simply undergoing a brief correction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum Updates Today: MoonBull’s Unique Ethereum Foundation Distinguishes It in the Competitive Meme Coin Space
- MoonBull ($MOBU) surges in Stage 6 presale with 7,244% ROI potential, leveraging Ethereum's security and deflationary tokenomics. - A structured referral system offers 15% extra tokens and USDC bonuses, driving $600K+ raised and 2,000+ holders. - Unlike meme coins, MoonBull's Ethereum-based model with staking and governance aims for sustainability, contrasting with volatile alternatives like TRUMP and XRP . - Analysts caution about crypto volatility, emphasizing ROI projections depend on market condition
From Pharmaceuticals to Blockchain: Lite Strategy's $100 Million LTC Reserve Disrupts Traditional Finance
- Lite Strategy (LITS) becomes first U.S. publicly traded company to adopt Litecoin as primary reserve asset after $100M private placement. - Partnership with crypto firm GSR and Litecoin creator Charlie Lee on board aims to institutionalize digital treasury management amid volatile markets. - $12.21M working capital and 12.39 current ratio highlight liquidity strength despite 18% YTD stock decline and mixed institutional investor reactions. - Strategic shift from pharmaceuticals to crypto reserves challen
Malaysia’s Broad Trade Approach Counters Trump Tariffs, Fuels 5.2% Economic Expansion
- Malaysia navigated Trump's 2025 tariffs via trade diversification and diplomacy, avoiding panic amid global market shocks. - U.S. reduced tariffs to 19% in October 2025 after Malaysia opened markets, coinciding with 5.2% Q3 GDP growth driven by exports and fiscal discipline. - Strategic trade ties with China, Singapore, and U.S. mitigated protectionist impacts, supported by ASEAN coordination and non-retaliatory policies. - Malaysia's $250M investment in semiconductor design and renewable energy reflects
Lite Strategy’s Balancing Game in Crypto-Pharma: Is It Possible to Manage Instability and Tradition Together?
- Lite Strategy (LITS) rebranded from MEI Pharma to focus on Litecoin , acquiring 929,548 LTC via a $100M PIPE in July 2025. - The company partners with GSR for crypto treasury management and launched a $25M share repurchase program in October 2025. - LITS holds $12.21M in working capital with no debt, while balancing pharmaceutical asset sales (e.g., ME-344) with crypto investments. - Despite strong liquidity (current ratio 12.39), the stock faces volatility risks and regulatory uncertainties in its crypt
Trending news
MoreCrypto prices
More
